Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived.
Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.
JC Virus Infects Neurons and Glial Cells in the Hippocampus.
CMTX Disorder and CamKinase.
Fampridine-PR (prolonged released 4-aminopyridine) is not effective in patients with inflammatory demyelination of the peripheral nervous system.
Myelin-specific T helper 17 cells promote adult hippocampal neurogenesis through indirect mechanisms.
Catalytic autoantibodies against myelin basic protein (MBP) isolated from serum of autistic children impair in vitro models of synaptic plasticity in rat hippocampus.
A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune Encephalomyelitis
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits.
Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
The spectrum of leukodystrophies in children: Experience at a tertiary care centre from North India.
Nerve conduction and electromyography studies.
MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy.
Pediatric multiple sclerosis: Clinical features and outcome.
Update on therapeutic options for multiple sclerosis.
Apathy in multiple sclerosis: gender matters.
Real-World Assessment of Relapse, Medical Costs and Persistency of Multiple Sclerosis Patients Treated With Subcutaneous Interferon β-1a.
[Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
The pathogenic relevance of αM-integrin in Guillain-Barré syndrome.
Rehabilitation in Multiple Sclerosis: a Systematic Review of Systematic Reviews.
Mixed emotions: the contribution of alexithymia to the emotional symptoms of autism.
Myelin repair by transplantation of myelin-forming cells in globoid cell leukodystrophy.
Effect of fish oil on glutathione redox system in multiple sclerosis.
Enhanced glucocorticoid receptor signaling in T cells impacts thymocyte apoptosis and adaptive immune responses.
Characterization of the encephalitogenic immune response in a model of multiple sclerosis.
Pages
« first
‹ previous
…
688
689
690
691
692
693
694
695
696
…
next ›
last »